BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38669103)

  • 1. Promoter hypomethylated PDZK1 acts as a tumorigenic gene in glioma by interacting with AKT1.
    Ren X; Deng D; Xiang S; Feng J
    Aging (Albany NY); 2024 Apr; 16(8):7174-7187. PubMed ID: 38669103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway.
    Zhang T; Ji D; Wang P; Liang D; Jin L; Shi H; Liu X; Meng Q; Yu R; Gao S
    Cancer Lett; 2018 Feb; 415():151-163. PubMed ID: 29233656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway.
    Gao X; Jiang W; Ke Z; Huang Q; Chen L; Zhang G; Li C; Yu X
    Biochem Biophys Res Commun; 2022 Jan; 586():34-41. PubMed ID: 34826698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis.
    Cai H; Yu Y; Ni X; Li C; Hu Y; Wang J; Chen F; Xi S; Chen Z
    Cell Death Dis; 2020 Dec; 11(12):1032. PubMed ID: 33268783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mirna-383-5p Functions as an Anti-oncogene in Glioma through the Akt/mTOR Signaling Pathway by Targeting VEGFA.
    Liu Y; Wang Z; Tang Z; Fu Y; Wang L
    Curr Cancer Drug Targets; 2024; 24(4):463-475. PubMed ID: 37592783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome.
    Mueller S; Phillips J; Onar-Thomas A; Romero E; Zheng S; Wiencke JK; McBride SM; Cowdrey C; Prados MD; Weiss WA; Berger MS; Gupta N; Haas-Kogan DA
    Neuro Oncol; 2012 Sep; 14(9):1146-52. PubMed ID: 22753230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation.
    Zhao N; Guo Y; Zhang M; Lin L; Zheng Z
    Oncol Rep; 2010 May; 23(5):1443-7. PubMed ID: 20372862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enolase-phosphatase 1 acts as an oncogenic driver in glioma.
    Wang B; Xu X; Liu X; Wang D; Zhuang H; He X; Han T; Hong J
    J Cell Physiol; 2021 Feb; 236(2):1184-1194. PubMed ID: 32654229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma.
    Liu PJ; Ye YX; Wang YX; Du JX; Pan YH; Fang XB
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6612-6620. PubMed ID: 31378903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas.
    Gao S; Sha Z; Zhou J; Wu Y; Song Y; Li C; Liu X; Zhang T; Yu R
    Cancer Biol Med; 2021 Feb; 18(1):88-104. PubMed ID: 33628587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Protease Serine 8 Inhibits Glioma Cell Proliferation, Migration, and Invasion via Suppressing the Akt/mTOR Signaling Pathway.
    Yang HY; Fang DZ; Ding LS; Hui XB; Liu D
    Oncol Res; 2017 Jul; 25(6):923-930. PubMed ID: 27983922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX; Zhang ZP; Zhao J; Liu JP
    Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway.
    Zhang L; Liang X; Li Y
    Oncol Rep; 2017 Oct; 38(4):2408-2416. PubMed ID: 28791407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3β/β-catenin pathway.
    Wang M; Li C; Shi W
    Biofactors; 2021 Jul; 47(4):600-611. PubMed ID: 33759248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-379 inhibits cell proliferation and invasion in glioma via targeting metadherin and regulating PTEN/AKT pathway.
    Li L; Zhang H
    Mol Med Rep; 2018 Mar; 17(3):4049-4056. PubMed ID: 29286115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA KB-1460A1.5 inhibits glioma tumorigenesis via miR-130a-3p/TSC1/mTOR/YY1 feedback loop.
    Xu L; Wu Q; Yan H; Shu C; Fan W; Tong X; Li Q
    Cancer Lett; 2022 Jan; 525():33-45. PubMed ID: 34728310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FLOT2 upregulation promotes growth and invasion by interacting and stabilizing EphA2 in gliomas.
    Song T; Hu Z; Liu J; Huang W
    Biochem Biophys Res Commun; 2021 Apr; 548():67-73. PubMed ID: 33631676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas.
    Zhu Y; Zhang X; Qi L; Cai Y; Yang P; Xuan G; Jiang Y
    Oncotarget; 2016 Mar; 7(12):14429-40. PubMed ID: 26894862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.